Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

Southern Methodist University biology researchers are uncovering how brain, heart, and lung connections may hold the key to ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Epilepsy surgery could be for you if you have drug resistant ... It can record unusual activity that is sometimes not detected by EEG. It can also track where the activity is more precisely. During ...

New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people in the United States ...

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Fact: Seizure and epilepsy disrupt the high-risk jobs such as that of pilots, drivers, train drivers, jobs involving heavy machinery. It has no impact on day-to-day activities. Fact: Seizure leads ...

Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...